Anal intraepithelial neoplasia (AIN) is a potentially premalignant change found in the anal canal. It was first described by the Danish pathologists Fenger and Nielsen. ' The description and grading of the morphological changes, seen in both cervical and AIN, histologically, are very similar, differing only in the degree of keratinisation. Richart originally described the grading system in the cervix,2 and these criteria have been clearly set out in a paper by Buckley et al. 3 Fenger has used a similar system for reporting changes seen in the anus. 4 Both grading systems divide the severity of dysplasia into three grades: I, II, and III. The grades are differentiated by the amount of the epithelium that is affected. In grade I only the lowest third of the epithelium is affected, in grade II the lower two thirds are affected, and in grade III the whole epithelium is affected. In dysplasia the hyperchromatic nuclei are enlarged, with a relative increase in the nuclear to cytoplasmic volume ratio, mitotic figures, and acanthosis.
The histological assessment of cervical dysplasia seems to be subjective and prone to both inter-and intraobserver variation. 5 Robertson et al assessed the observer variability in the histopathological reporting of sections from 100 cervical biopsy specimens, by 12 consultant histopathologists.6 This study showed poor differentiation between low grades of dysplasia but good agreement on the diagnosis of high grade dysplasia (CIN III).
Very little agreement was found between observers on the identification of the changes of human papillovirus (HPV) infection. 6 A second study by De Vet et al examined the same problem of observer variability. Four experienced histopathologists were asked to grade 106 cervical biopsy specimens into five groups according to the degree of dysplasia. This study showed again that there was considerable variability in the reporting of the same slides by different pathologists. 7 The difficulties surrounding the diagnosis of dysplasia may produce problems when deciding on a therapeutic strategy. In the cervix there is good evidence to confirm that about 30% of grade III lesions will progress to invasive cancer within 10 years, if left untreated. 8 The natural history of the lower grades of cervical cancer is less well demarcated, although some studies have indicated a high progression rate of low grade lesions to high grade lesions over a short period of time. It is therefore unlikely that any large study of the natural history of low grade dysplasia will now be undertaken, due to ethical considerations.
This leaves the clinician with two choices, given the present grading system: (1) The first choice is to treat all patients with repeated low grade smears aggressively, in an attempt to eradicate the disease. This often means, however, that the patients have frequent and multiple treatments for what may turn out to be a condition which will usually remain static or regress. (2) The other option is to enrol the patients with repeated low grade smears into a regular colposcopic follow up clinic and only ablate if there is evidence of progression to more severe disease. This therapeutic dilemma, which is partly related to grading difficulties, has been recognised by Richart. He has proposed an alternative grading system that divides dysplasia into two groups-major and minor.9 This may allow clinicians to adopt an "expectant" policy with regard to the minor abnormalities, and confine surgery to the major dysplasia group.
The grading system described by Fenger for use in the anus has yet to be tested for its reproducibility. 4 All identification markings on the slides were removed and each slide was allocated a random number between 1 and 100 (a complete record was kept of the original identification data and the new numbers, to allow relabelling at the completion of the study).
The slides were sent to five histopathologists for reporting. All five histopathologists were consultants. Three consultants had a special interest in gastroenterological pathology and had considerable experience of assessing anal dysplasia. The other two consultant pathologists both had a special interest in cervical histopathology and had extensive experience of Richart's old system for assessing cervical intraepithelial dysplasia.
The results were assessed using both weighted and unweighted K analyses. This Many of the patients at risk of AIN are immunosuppressed and it is important in these patients to limit treatment to those who are at greatest risk of progression to invasive cancer. The present grading system is inadequate for a reliable differentiation to be made between the grades of AIN. This may be due partly to the effects of HPV infection, which can produce considerable interpretative difficulties.
In conclusion, it is clear from these studies that there is considerable interobserver variation in the reporting of AIN. A further study is now in progress to assess the reliability of a simplified classification, dividing AIN into two grades, high and low.
